4524.T
MORISHITA JINTAN CO.,LTD.
スタンダード · 医薬品 · 医薬品 · JP
JPY 2,243.00
−0.04%Income statement
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 12.7B | 12.7B | 12.8B | 12.4B | 11.4B |
| Cost of Revenue | 1.8B | 6.6B | 6.8B | 6.4B | 6.0B |
| Gross Profit | 1.5B | 6.1B | 6.0B | 6.0B | 5.3B |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 1.3B | 5.4B | 5.2B | 5.3B | 4.7B |
| General & Admin Expense | — | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 1.3B | 5.4B | 5.2B | 5.3B | 4.7B |
| Cost and Expenses | 12.0B | 12.0B | 12.0B | 11.7B | 10.8B |
| Operating Income (EBIT) | 692.0M | 692.0M | 804.0M | 716.0M | 569.0M |
| Non-Operating | |||||
| Interest Income | — | 1.0M | — | — | — |
| Interest Expense | 5.0M | 22.0M | 8.0M | 2.0M | 2.0M |
| Net Interest Income | (5.0M) | (21.0M) | (8.0M) | (2.0M) | (2.0M) |
| Other Non-Op Income/Expense | 15.0M | 81.0M | 67.0M | 100.0M | 54.0M |
| Non-Operating Income (excl Interest) | 22.0M | 104.0M | 77.0M | 102.0M | 57.0M |
| EBT (Pre-Tax Income) | 209.0M | 773.0M | 772.0M | 820.0M | 623.0M |
| Income Tax Expense | 46.0M | 144.0M | 225.0M | 123.0M | 131.0M |
| Bottom Line | |||||
| Net Income | 628.0M | 628.0M | 547.0M | 697.0M | 491.0M |
| Earnings from Cont. Ops | — | — | — | — | — |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 628.0M | 628.0M | 547.0M | 697.0M | 491.0M |
| Per Share | |||||
| Basic EPS | ¥153 | ¥153 | ¥134 | ¥171 | ¥121 |
| Diluted EPS | ¥153 | ¥153 | — | — | — |
| Revenue Per Share | ¥3,098 | ¥3,098 | ¥3,122 | ¥3,037 | ¥2,783 |
| Shares | |||||
| Basic Shares Outstanding | 4.1M | 4.1M | 4.1M | 4.1M | 4.1M |
| Diluted Shares Outstanding | — | — | — | — | — |
| Profitability Metrics | |||||
| EBITDA | — | 1.3B | 1.4B | 1.3B | 1.2B |
| D&A | — | 596.0M | 578.0M | 576.0M | 627.0M |
| EBIT | 692.0M | 692.0M | 804.0M | 716.0M | 569.0M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026